Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Nov 9, 2020 QUARTERLY REPORT
DEF 14A Nov 3, 2020 DEFINITIVE PROXY STATEMENT
UPLOAD Nov 2, 2020
PRER14A Oct 30, 2020 REVISED PRELIMINARY PROXY STATEMENT
CORRESP Oct 29, 2020
8-K Oct 29, 2020 CURRENT REPORT
UPLOAD Oct 29, 2020
PRE 14A Oct 20, 2020 PRELIMINARY PROXY STATEMENT
10-Q Aug 7, 2020 QUARTERLY REPORT
8-K Jul 16, 2020 CURRENT REPORT
8-K Jun 30, 2020 CURRENT REPORT
DEFA14A Jun 24, 2020 DEFINITIVE ADDITIONAL MATERIALS
4 Jun 23, 2020 PRIMARY DOCUMENT
DEF 14A Jun 2, 2020 DEFINITIVE PROXY STATEMENT
PRE 14A May 15, 2020 PRELIMINARY PROXY STATEMENT
10-Q May 7, 2020 QUARTERLY REPORT
3 Apr 8, 2020 PRIMARY DOCUMENT
8-K Mar 31, 2020 CURRENT REPORT
8-K Mar 27, 2020 CURRENT REPORT
DEFA14A Mar 25, 2020 DEFINITIVE ADDITIONAL MATERIALS
10-K Mar 10, 2020 ANNUAL REPORT
8-K Mar 4, 2020 8-K
DEF 14A Mar 3, 2020 DEFINITIVE PROXY STATEMENT
PRE 14A Feb 21, 2020 PRELIMINARY PROXY STATEMENT
425 Feb 19, 2020 425
← Newer Page 18 of 23 · 551 filings Older →